Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment

Tuberculosis remains one of the world’s deadliest infectious diseases, accounting for nearly 1.3 million deaths every year. Tuberculosis treatment is challenging because of the toxicity, decreased bioavailability at the target site of the conventional drugs and, most importantly, low adherence of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanieh, Patrizia Nadia, Consalvi, Sara, Forte, Jacopo, Cabiddu, Gianluigi, De Logu, Alessandro, Poce, Giovanna, Rinaldi, Federica, Biava, Mariangela, Carafa, Maria, Marianecci, Carlotta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955761/
https://www.ncbi.nlm.nih.gov/pubmed/35335983
http://dx.doi.org/10.3390/pharmaceutics14030610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955761/
https://www.ncbi.nlm.nih.gov/pubmed/35335983
http://dx.doi.org/10.3390/pharmaceutics14030610

Ejemplares similares